has been cited by the following article(s):
[1]
|
Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
The Journal of Sexual Medicine,
2020
DOI:10.1016/j.jsxm.2020.06.022
|
|
|
[2]
|
Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
The Journal of Sexual Medicine,
2020
DOI:10.1016/j.jsxm.2020.06.022
|
|
|